Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases


Por: Petersson F., Gatalica Z., Grossmann P., Montiel, MDP, Cabrero, IA, Bulimbasic S., Swatek A., Straka L., Tichy T., Hora M., Kuroda N., Legendre B., Michal M., Hes O.

Publicada: 1 abr 2010
Resumen:
Hybrid oncocytic/chromophobe tumors (HOCT) of the kidney have been described in patients with Birt-Hogg-Dub, syndrome (BHD) and in association with renal oncocytosis without BHD. HOCT in patients without evidence of BHD or renal oncocytosis is exceedingly rare, and these cases have been poorly characterized. We have identified and studied 14 cases of HOCT from previously diagnosed renal oncocytomas (398 cases) and chromophobe renal cell carcinomas (351 cases) without evidence of BHD or renal oncocytosis. Immunohistochemical, ultrastructural, and molecular genetic studies analyzing numerical chromosomal changes, loss of heterozygosity for chromosome 3p, and mutation status of VHL, c-kit, PDGFR, and folliculin (FLCN) genes were performed. HOCTs were identified in nine men and five women (age range 40-79 years). The size of tumors ranged from 2 to 11 cm. All tumors displayed a solid alveolar architecture and were composed of cells with abundant granular eosinophilic oncocytic cytoplasm wi

Filiaciones:
Petersson F.:
 Department of Pathology, National University Hospital System, Singapore, Singapore

 Department of Pathology, Charles University, Charles University Hospital Plzen, Alej Svobody 80, Plzen 304 60, Czech Republic

Gatalica Z.:
 Department of Pathology, Creighton University, School of Medicine, Omaha, NE, United States

Grossmann P.:
 Department of Pathology, Charles University, Charles University Hospital Plzen, Alej Svobody 80, Plzen 304 60, Czech Republic

Bulimbasic S.:
 Department of Pathology, University Hospital Dubrava, Zagreb, Croatia

Swatek A.:
 Department of Pathology, University of Kansas, Kansas City, MO, United States

Straka L.:
 Department of Pathology, Regional Hospital Presov, Prešov, Slovakia

Tichy T.:
 Department of Pathology, Palacky's University Hospital Olomouc, Olomouc, Czech Republic

Hora M.:
 Department of Urology, Charles University, Charles University Hospital Plzen, Plzen, Czech Republic

Kuroda N.:
 Department of Pathology, Red Cross Hospital Kochi, Kochi, Japan

Legendre B.:
 Transgenomic, Inc., Omaha, NE, United States

Michal M.:
 Department of Pathology, Charles University, Charles University Hospital Plzen, Alej Svobody 80, Plzen 304 60, Czech Republic

Hes O.:
 Department of Pathology, Charles University, Charles University Hospital Plzen, Alej Svobody 80, Plzen 304 60, Czech Republic

Department of Pathology, Institute Nacional de Cancerologia, Mexico City, Mexico
Department of Pathology, Centro Medico, Mexico City, Mexico
ISSN: 09456317
Editorial
SPRINGER, 233 SPRING STREET, NEW YORK, NY 10013 USA, Alemania
Tipo de documento: Article
Volumen: 456 Número: 4
Páginas: 355-365
WOS Id: 000276516400002
ID de PubMed: 20300772